& Koch, G
There are other forms of reuptake inhibitors, which can function on other chemicals, such as dopamine, norepinephrine, adenosine, and more
The VA-IMPACT trial is attempting to fill this gap by evaluating cardiovascular outcomes in patients with pre-diabetes and established CVD treated with metformin versus placebo (NCT02915198)
Interventions targeting microbiota are a prospective avenue for slowing disease progression
Dr Amit Srivastava Weight Loss Specialist UK November 1, 2025 Dr Amit Srivastava Weight Loss Specialist UK 4 min read September 25, 2025 Dr Amit Srivastava Weight Loss Specialist UK 4 min read September 15, 2025 Dr Amit Srivastava Weight Loss Specialist UK 2 min read
In the retatrutide phase 2 trial at 48 weeks, the 12 mg group reported 100% of participants losing at least 5%, 93% losing at least 10%, and 83% losing at least 15% though this was a smaller, earlier-stage study